Synonyms: DH-581 | Lorelco®
probucol is an approved drug (FDA (1977))
Compound class:
Synthetic organic
Comment: Probucol is a lipid-lowering drug. Marketing of this drug was ceased in 1995 in the US due to safety concerns.
|
|
Classification | |
Compound class | Synthetic organic |
Approved drug? | Yes (FDA (1977)) |
Withdrawn drug? | Yes |
IUPAC Name |
2,6-di-tert-butyl-4-({2-[(3,5-di-tert-butyl-4-hydroxyphenyl)sulfanyl]propan-2-yl}sulfanyl)phenol |
International Nonproprietary Names | |
INN number | INN |
2928 | probucol |
Synonyms |
DH-581 | Lorelco® |
Database Links | |
CAS Registry No. | 23288-49-5 |
ChEMBL Ligand | CHEMBL608 |
DrugBank Ligand | DB01599 |
DrugCentral Ligand | 2269 |
GtoPdb PubChem SID | 178103851 |
PubChem CID | 4912 |
Search Google for chemical match using the InChIKey | FYPMFJGVHOHGLL-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | FYPMFJGVHOHGLL |
Search PubMed clinical trials | probucol |
Search PubMed titles | probucol |
Search PubMed titles/abstracts | probucol |
UniChem Compound Search for chemical match using the InChIKey | FYPMFJGVHOHGLL-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | FYPMFJGVHOHGLL-UHFFFAOYSA-N |
Wikipedia | Probucol |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
Probucol (links to external site)
Cat. No. 2775 |